Antengene Corporation

About:

Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.

Website: http://antengene.com/

Top Investors: Qiming Venture Partners, Fidelity, GIC, Hillhouse Investment, TF Capital

Description:

Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.The company focuses on providing patients with innovative anti-tumor and anti-cancer therapies through new drug development, clinical research and drug production, enabling physicians to meet unmet medical needs in Asia.

Total Funding Amount:

$238M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2016-01-01

Founders:

Jay Mei

Number of Employees:

251-500

Last Funding Date:

2020-07-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai